Anthera Pharmaceuticals Financials

ANTHDelisted Stock  USD 0.0001  0.00  0.00%   
We suggest to use Anthera Pharmaceuticals fundamental analysis to find out if markets are presently mispricing the company. Put another way you can use it to find out if Anthera Pharmaceuticals is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to interpolate and analyze data for thirty available fundamental indicators for Anthera Pharmaceuticals, which can be compared to its peers. The stock experiences a normal downward fluctuation but is a risky buy. Check odds of Anthera Pharmaceuticals to be traded at $1.0E-4 in 90 days.
  
Understanding current and past Anthera Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Anthera Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Anthera Pharmaceuticals' assets may result in an increase in income on the income statement.

Anthera Pharmaceuticals Stock Summary

Anthera Pharmaceuticals competes with Salarius Pharmaceuticals, SAB Biotherapeutics, Vaccinex, GeoVax Labs, and Connect Biopharma. Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas. Anthera Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 21 people.
Specialization
Healthcare, Biotechnology
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
ISINUS03674U3005
CUSIP03674U201 03674U300 03674U102
LocationCalifornia; U.S.A
Business AddressThe Pennzoil Building,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.anthera.com
Phone410 350 1839
CurrencyUSD - US Dollar

Anthera Pharmaceuticals Key Financial Ratios

Anthera Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from Anthera Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of Anthera Pharmaceuticals over time and compare it to other companies across industries.

Anthera Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Anthera Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Anthera Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Anthera Pharmaceuticals competition to find correlations between indicators driving Anthera Pharmaceuticals's intrinsic value. More Info.
Anthera Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Anthera Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Anthera Pharmaceuticals' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Anthera Pharmaceuticals Market Pulse

 Quote1.0E-4
 Change(%) 0.00  
 Change0.00 
 Open1.0E-4
 Low1.0E-4
 High1.0E-4
 Volume0
 ExchangePINK
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Consideration for investing in Anthera Pink Sheet

If you are still planning to invest in Anthera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anthera Pharmaceuticals' history and understand the potential risks before investing.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments